Previous 10 | Next 10 |
Shares of Co-Diagnostics (NASDAQ: CODX) were tanking on Friday with the stock down 14.6% as of 10:07 a.m. EDT. The big drop came after the molecular diagnostics company provided its fourth-quarter update after the market close on Thursday. Co-Diagnostics easily beat the cons...
HighPoint Resources (HPR) -17%.Vuzix (VUZI) -16% on pricing $85M stock offering.Cellect Biotechnology (APOP) -12%GAN (GAN) -10% on Q4 earnings release.Hall of Fame Resort & Entertainment (HOFV) -9%.Cinedigm (CIDM) -8%.Co-Diagnostics (CODX) -8% on FY earnings ...
No one expected Co-Diagnostics (NASDAQ: CODX) to follow up its fantastic gain of nearly 940% in 2020 with anything close to that level this year. However, the molecular-diagnostics stock got off to a great start. The momentum is losing steam now, though. Co-Diagnostics announced...
Co-Diagnostics, Inc. (CODX) Q4 2020 Results Earnings Conference Call March 25, 2021, 04:30 PM ET Company Participants Andrew Benson - Head of Investor Relations Dwight Egan - Chairman, CEO & President Brian Brown - CFO Reed Benson - Secretary & General Counsel Conference Call Particip...
Co-Diagnostics ([[CODX]] -2.3%) announced its Q4 2020 financial results today. Despite a revenue beat, the earnings have failed to meet the consensus and shares are trading ~7.8% lower in after-hours.Driven by sales of the Logix Smart™ COVID-19 test, the quarterly r...
Co-Diagnostics (CODX): FY GAAP EPS of $1.52 misses by $0.04.Revenue of $74.55M (+33786.4% Y/Y) beats by $2.18M; primarily due to sales of Logix Smart COVID-19 Tests throughout the world.Cash, cash equivalents, and marketable securities totaled $47.3 million as of December&...
Co-Diagnostics Reports Fourth-Quarter and Full-Year 2020 Financial Results Record quarterly results highlighted by revenue of $27.1 million and pre-tax income of $15.8 million PR Newswire SALT LAKE CITY , March 25, 2021 /PRNewswire/ -- Co-Diagnostics, In...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Headquartered in Utah, molecular diagnostics company Co-Diagnostics (NASDAQ: CODX ) offers health-oriented products with a focus on genetics technology. In the era of the Covid-19 pandemic, CODX stock has become ...
Co-Diagnostics, Inc. Announces Fourth-Quarter and Full-Year 2020 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , March 18, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platfo...
USA News Group / In the wake of the US presidential election, calls for economies to reopen are beginning to mount from governors such as Andrew Cuomo in New York and Gavin Newsom in California , and mayors like Chicago’s Lori Lightfoot. As regulators contemplate the ...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago PR Newswire SALT LAKE CITY , July 29, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company wi...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...